Glaxo's Strategy For Drug Performance Units Is Showing Promise, Slaoui Says
This article was originally published in The Pink Sheet Daily
Executive Summary
R&D Chairman Moncef Slaoui provides update on drug performance units one year out at Windhover's Pharmaceutical Strategic Alliance Conference.